Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
{{output}}
Individuals with type 2 diabetes mellitus have an increased risk of developing Alzheimer's disease (AD). GLP-1 receptor agonists (GLP-1RAs) are used for glycemic control in diabetes and show potential neuroprotective properties, but their effects on AD and th... ...
